Solution Compounds

SLU-PP-332 is a synthetic small-molecule research compound best known as a pan-agonist of ERRα, ERRβ, and ERRγ, a family of nuclear receptors involved in mitochondrial function, oxidative metabolism, and cellular energy regulation. Its main interest lies in its ability to shift tissues toward a more oxidative metabolic state. Rather than acting like a stimulant, it appears to influence upstream transcriptional programs that regulate how cells produce and use energy. This includes effects on mitochondrial biogenesis, fatty acid oxidation, oxidative phosphorylation, and overall fuel preference. In preclinical studies, SLU-PP-332 has been associated with increased mitochondrial respiration, enhanced oxidative muscle remodeling, greater reliance on fat oxidation, higher energy expenditure, and improved endurance-related parameters in animal models. It has also shown activity in experimental settings involving metabolic dysfunction, liver fat accumulation, cardiac energy impairment, and age-related mitochondrial decline. Overall, SLU-PP-332 is best described as a preclinical metabolic reprogramming compound with exercise-mimetic and oxidative metabolic activity. It is relevant for research into mitochondrial biology, fuel utilization, and ERR-driven transcriptional regulation.